Clinical Trial Update: Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509 [Phase 2]

View source ↗

Summary

Phase 2 trial of SB-509 for stem cell mobilization in subjects with diabetic polyneuropathy has completed. The trial included subjects with Type 1 and Type 2 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• SB-509

Snippet

Sponsor: Sangamo Therapeutics | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED